Biased and g protein-independent signaling of chemokine receptors
Related Experiment Video
Updated: Apr 27, 2026

Imaging G-protein Coupled Receptor GPCR-mediated Signaling Events that Control Chemotaxis of Dictyostelium Discoideum
Published on: September 20, 2011
Anne Steen1, Olav Larsen1, Stefanie Thiele1
1Laboratory for Molecular Pharmacology, Department of Neuroscience and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen , Denmark.
Abstract:
Biased signaling or functional selectivity occurs when a 7TM-receptor preferentially activates one of several available pathways. It can be divided into three distinct forms: ligand bias, receptor bias, and tissue or cell bias, where it is mediated by different ligands (on the same receptor), different receptors (with the same ligand), or different tissues or cells (for the same ligand-receptor pair). Most often biased signaling is differentiated into G protein-dependent and β-arrestin-dependent signaling. Yet, it may also cover signaling differences within these groups. Moreover, it may not be absolute, i.e., full versus no activation. Here we discuss biased signaling in the chemokine system, including the structural basis for biased signaling in chemokine receptors, as well as in class A 7TM receptors in general. This includes overall helical movements and the contributions of micro-switches based on recently published 7TM crystals and molecular dynamics studies. All three forms of biased signaling are abundant in the chemokine system. This challenges our understanding of "classic" redundancy inevitably ascribed to this system, where multiple chemokines bind to the same receptor and where a single chemokine may bind to several receptors - in both cases with the same functional outcome. The ubiquitous biased signaling confers a hitherto unknown specificity to the chemokine system with a complex interaction pattern that is better described as promiscuous with context-defined roles and different functional outcomes in a ligand-, receptor-, or cell/tissue-defined manner. As the low number of successful drug development plans implies, there are great difficulties in targeting chemokine receptors; in particular with regard to receptor antagonists as anti-inflammatory drugs. Un-defined and putative non-selective targeting of the complete cellular signaling system could be the underlying cause of lack of success. Therefore, biased ligands could be the solution.
Insights
Biased signaling in chemokine systems, where receptors activate specific pathways, offers new drug development solutions. This functional selectivity challenges classic redundancy, revealing context-defined roles and potential therapeutic strategies.
Area of Science:
- Pharmacology
- Molecular Biology
- Structural Biology
Background:
- Biased signaling, or functional selectivity, occurs when 7 transmembrane (7TM) receptors preferentially activate specific signaling pathways.
- It manifests as ligand bias, receptor bias, or tissue/cell bias, often differentiated by G protein- or β-arrestin-dependent pathways.
Purpose of the Study:
- To discuss biased signaling within the chemokine system, exploring its structural underpinnings in chemokine receptors and Class A 7TM receptors.
- To re-evaluate the perceived redundancy in the chemokine system in light of ubiquitous biased signaling.
Main Methods:
- Analysis of recently published 7TM crystal structures and molecular dynamics studies.
- Examination of structural bases for biased signaling, including helical movements and micro-switches.
Main Results:
- All three forms of biased signaling are prevalent in the chemokine system, challenging the notion of simple redundancy.
- Biased signaling introduces specificity, creating a complex, promiscuous interaction pattern with context-defined roles and outcomes.
- Structural insights reveal mechanisms contributing to biased signaling in 7TM receptors.
Conclusions:
- Ubiquitous biased signaling in chemokines confers a previously unrecognized specificity, moving beyond the concept of classic redundancy.
- Difficulties in targeting chemokine receptors for drug development may stem from non-selective targeting of the entire signaling system.
- Biased ligands represent a promising therapeutic strategy for overcoming challenges in chemokine receptor-targeted drug development.
More Related Videos
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
10:03Rapid and Robust Analysis of Cellular and Molecular Polarization Induced by Chemokine Signaling
Published on: December 12, 2014
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
IP3/DAG Signaling Pathway
Activation and Inactivation of G Proteins
G-protein Coupled Receptors
G-protein Coupled Receptors
Chemotaxis and Direction of Cell Migration